Jianfeng International Trade Held Plasticizing Market Industry-Finance Collaborative Development Forum
Release time:
2020-12-11
Jianfeng International Trade Held Forum on Coordinated Development of Production and Finance in Plasticizing Market
On October 4, Jianfeng International Trading Company and Yong 'an Futures Co., Ltd. jointly held the "Summit Forum on Coordinated Development of Production and Finance in Plasticizing Market in 2020". Representatives of major plasticizing manufacturers and traders from Shaanxi and Xinjiang, as well as more than 70 relevant units in the industry, gathered together to discuss risk management and development opportunities in plasticizing industry.
Since the beginning of this year, global financial and commodity markets have been highly volatile due to the impact of the new crown epidemic, and increased market uncertainty has led to significant fluctuations in plasticized commodity prices. In recent years, in order to realize the effective linkage and mutual supplement between futures and spot, on-market and off-market, Dalian Commodity Exchange has launched the off-market platform standard warehouse receipt trading business relying on the comprehensive service platform, and on October 30, it has realized the full coverage of three plasticized varieties of polyvinyl chloride, polyethylene and polypropylene. In order to better play the role of futures delivery warehouse, promote the development of plastic industry in the region, better perform the duties of futures delivery warehouse of Dalian Commodity Exchange, and serve related industries and industrial chain, with the support of Dalian Commodity Exchange, Jianfeng International Trade and Yongan Futures jointly held this forum. Yu Jianhong, general manager of
Group Company, attended the meeting and delivered a speech. He expressed his gratitude and welcome to the guests who came to the forum, and said that Jianfeng International Trade had become the designated delivery warehouse of PVC on Dalian Commodity Exchange as early as 2009, and had rich experience in futures delivery warehouse business. This forum will focus on the actual needs of the upstream and downstream industries of plasticizing, with the theme of exchanging experience, promoting docking, and discussing "plasticizing market industry-finance coordination", on how to serve the real economy and create a more efficient plasticizing business value chain operation system Exchange. Let the production plants, buyers and traders quickly understand the futures delivery and options business, in-depth discussion of "plastic industry market trends and prospects", open up industry growth points and new opportunities, and build a plastic futures market ecosystem. At present, the new crown epidemic is still raging around the world, the complexity and risk of world economic development is still increasing, the pattern of market competition is also undergoing unprecedented changes, the industry relying on the value chain or ecosystem competition advantages gradually emerged. He hopes that various manufacturers and traders can work together with the peak international trade cooperation and common development. In the
forum, experts from Dalian Commodity Exchange, Chaojing Investment and Hongze Research introduced and analyzed topics such as the standard warehouse order trading business of the OTC platform, the post-epidemic pattern changes and investment opportunities in 2021, and the review and outlook of the polyolefin market. Shao Huijie, deputy director of the Peak International Trade Office, introduced in detail the business characteristics and delivery process rules of the peak delivery warehouse from the aspects of the definition, rights and obligations of the delivery warehouse, the delivery warehouse process and the warehouse charging standard. He said that the peak delivery warehouse will rely on the futures and spot upstream and downstream channel resources of the delivery warehouse, and combine the two markets of on-site trading and over-the-counter trading to promote the realization of the functions of price discovery and hedging of futures varieties, efforts to promote the long-term development of the futures and spot markets. (Ni Yingzhen/Wen Huang Zhiyu/Photograph)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31